MAIA Biotechnology, Inc. ( ($MAIA) ) has shared an update. On December 10, 2025, MAIA Biotechnology announced a significant ...

In the northwest corner of Sioux Falls, an 80-acre campus opened its first building this year dedicated entirely to expanding ...

The Trump administration may have softened its language on China to maintain a fragile truce in their trade war, but Congress ...

From enabling more sustainable practices, to solving supply chain issues and inspiring creativity, here’s how biotech is ...

Congress is poised to pass the Biosecure Act after two years of incremental changes that watered down the bill’s curbs on Chinese biotechs ...

Ely Lilly’s announcement to invest $6 billion into a manufacturing plant opened up a partnership with the University of ...

The coming era of biosecurity will demand a broader and more adaptive approach as AI, powerful biological engineering ...

Denali Therapeutics ( ($DNLI) ) has shared an update. On December 9, 2025, Denali Therapeutics entered into an underwriting agreement with major ...

PharmAla Biotech Holdings Inc. ('PharmAla” or the 'Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules ...

WASHINGTON — The US House of Representatives passed the annual defense bill Wednesday, outlining a $900 billion budget that ...

Provisions on research security, grant policies, indirect cost rates, and more are packed into the latest version of the NDAA ...

Discover why AbbVie (ABBV) is rated Strong Buy, with robust 2025 growth, diversified revenues, and attractive valuation.